Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and decision-making in precision medicine.
A paper published in Biology Methods and Protocols, indicates that a new computational method may help researchers identify ...
Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...
New Computational Model Matches Drugs to Protein Synthesis Disruptors in Hereditary Diseases, Cancer
Genetic diseases that result from truncated proteins can be targeted by so-called nonsense suppression therapies—drugs that prevent protein translation from terminating prematurely. A new ...
SHANGHAI & BOSTON--(BUSINESS WIRE)--Perpetual Medicines today announced it has closed an $8 million seed financing to advance its integrated computational design and synthesis platform for peptide ...
On Monday, AI powerhouse Nvidia kicked off this year’s J.P. Morgan Healthcare Conference by announcing new and expanded partnerships aimed at embedding AI even deeper into drug discovery and ...
DAVIS, Calif.--(BUSINESS WIRE)--The OpenFold Consortium, a leading nonprofit artificial intelligence (AI) research consortium, today announced a preview release of OpenFold3, an open-source deep ...
Bissan Al-Lazikani (left) is a Professor of Genomic Medicine and Director of Therapeutics Data Science at The University of Texas MD Anderson Cancer Center (Houston, TX, USA), where she heads an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results